NVTS trades 24.1% above Wall Street's consensus target of $18.23.
Last 12 months price action with 12-month analyst target path
The base valuation assumes NVTS achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Navitas Semiconductor Corporation (NVTS) has a Wall Street consensus price target of $18.23, based on estimates from 8 covering analysts. With the stock currently trading at $24.02, this represents a potential downside of -24.1%. The company has a market capitalization of $5.54B.
Analyst price targets range from a low of $13.70 to a high of $21.00, representing a 40% spread in expectations. The median target of $20.00 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, NVTS trades at a trailing P/E of -42.1x. Analysts expect EPS to grow +69.2% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
WOLFWolfspeed, Inc. | $2.6B | $57.42 | $20.00 | -65.2% | Hold | — | 19 |
AEHRAehr Test Systems | $3.5B | $115.30 | $62.00 | -46.2% | Hold | — | 3 |
MPWRMonolithic Power Systems, Inc. | $76.8B | $1563.70 | $1615.00 | +3.3% | Buy | 65.2x | 25 |
ALGMAllegro MicroSystems, Inc. | $10.9B | $59.00 | $52.57 | -10.9% | Buy | 111.0x | 13 |
AEVAAeva Technologies, Inc. | $1.5B | $24.39 | $8.74 | -64.2% | Buy | — | 8 |
ONON Semiconductor Corporation | $47.7B | $121.62 | $94.25 | -22.5% | Buy | 39.4x | 46 |
STMSTMicroelectronics N.V. | $69.7B | $78.39 | $74.83 | -4.5% | Buy | 61.0x | 29 |
DIODDiodes Incorporated | $5.5B | $119.46 | $120.00 | +0.5% | Buy | 45.5x | 13 |
IXHLIncannex Healthcare Limited | $41M | $3.56 | — | — | — | — | — |
PSIXPower Solutions International, Inc. | $929M | $40.31 | $107.00 | +165.4% | Hold | 16.9x | 6 |
Quick answers to the most common questions about buying NVTS stock.
NVTS's consensus price target is $18.23, -24.1% below the current price of $24.02. The 8 analysts tracking NVTS see downside risk at present valuations.
NVTS has a consensus rating of "Hold" based on 8 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $18.23 implies -24.1% downside from current levels.
NVTS's current price is $24.02 with a consensus target of $18.23 (-24.1% implied move). Analyst estimates suggest the stock is overvalued at current levels.
The most bullish Wall Street analyst has a price target of $21 for NVTS, while the most conservative target is $13.7. The consensus of $18.23 represents the median expectation. These targets typically reflect 12-month expectations.
NVTS is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 4 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month NVTS stock forecast based on 8 Wall Street analysts shows a consensus price target of $18.23, with estimates ranging from $13.7 (bear case) to $21 (bull case). The median consensus rating is "Hold".
Analysts are cautious on NVTS, with 1 Sell ratings and a price target of $18.23 (-24.1% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
NVTS analyst price targets range from $13.7 to $21, a 40% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $18.23 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.